$30MSeries A, 27 May 2026
Series A from sole investor RA Capital to advance STM-01 toward pivotal trials
- Amount
- $30M
- Stage
- Series A
- Announced
- 27 May 2026
- Lead
- RA Capital Management
- Use of funds
- Series A from sole investor RA Capital to advance STM-01 toward pivotal trials
- Checked
- Announced by the company
- Sources
- Secretome Therapeutics raises $30M Series A from RA Capital businesswire.com
Secretome Therapeutics raises $30M Series A from RA Capital ventureburn.com